English (United Kingdom)Ukrainian (UA)
RESEARCH Protein Kinase Inhibitors CK2 Inhibitors 2-phenylisothiazolidin-3-one-1,1-dioxides


We have synthesized 40 new 2-phenylisothiazolidin-3-one-1,1-dioxide derivatives. The optimization based on biological screening data and molecular modeling resulted in a 10-fold increase in inhibitory activity compared with previously reported inhibitors of this class and led to the identification of 3-{[2-chloro-4-(1,1-dioxido-3-oxoisothiazolidin-2-yl)benzoyl]amino}benzoic acid, a potent inhibitor of human protein kinase CK2 (IC50 = 1.5 μM) (Fig. 1). 

Figure 1. The binding mode of 2-phenylisothiazolidin-3-one-1,1-dioxide inhibitor obtained with molecular docking. Intermolecular hydrogen bonds are indicated with dotted lines.

  • Design, synthesis and evaluation of 2-phenylisothiazolidin-3-one-1,1-dioxides as a new class of human protein kinase CK2 inhibitors. Chekanov MO, Ostrynska OV, Synyugin AR, Bdzhola VG, Yarmoluk SM. J Enzyme Inhib Med Chem. 2014, 29(3):338-343.  

Other kinase inhibitors research:

CK2 Inhibitors
1,3-thiazole-5-carboxylic acid derivatives Image
Novel CK2 inhibitors among 1,3-thiazole-4-carboxylic acid derivatives have been...


FGFR1 Inhibitors
N-phenylthieno[2,3-d]pyrimidin-4-amines Image
Thienopyrimidine derivatives have attracted great interest as protein kinase...


ASK1 Inhibitors
Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as Inhibitors of ASK1 Image
Virtual screening and biochemical screening allowed us to identify...


© 2012 All rights reserved
footer logo